Personal information

No personal information available

Activities

Collapse all

Employment (4)

Leids Universitair Medisch Centrum: Leiden, Zuid-Holland, NL

2014-10-01 to present | Resident (Anesthesiology)
Employment
Source: Self-asserted source
D Kleinloog

Tergooiziekenhuizen: Hilversum, North Holland, NL

2013-10-01 to 2014-09-30 | Resident (Intensive Care)
Employment
Source: Self-asserted source
D Kleinloog

P1Vital Ltd: Oxford, GB

2012-04-02 to 2013-03-14 | Medical Director
Employment
Source: Self-asserted source
D Kleinloog

Centre for Human Drug Research: Leiden, South Holland, NL

2008-10-01 to 2012-03-31 | Research Physician (CNS)
Employment
Source: Self-asserted source
D Kleinloog

Education and qualifications (3)

Universiteit Leiden: Leiden, Zuid-Holland, NL

2008-10-01 to 2014-04-01 | Philosopher's Degree (PhD) (Faculty of Medicine)
Education
Source: Self-asserted source
D Kleinloog

Dutch Society of Clinical Pharmacology and Biopharmacy: Nijmegen, NL

2008-11-19 to 2012-03-20 | Clinical Pharmacology
Education
Source: Self-asserted source
D Kleinloog

Maastricht University: Maastricht, Limburg, NL

2001-09-01 to 2007-06-25 | Medical Doctor (MD) (Faculty of Medicine)
Education
Source: Self-asserted source
D Kleinloog

Works (11)

Favourable outcome after prolonged veno-venous extracorporeal membrane oxygenation (V-V ECMO) support forPneumocystis jiroveciipneumonia in a renal transplant recipient

BMJ Case Reports
2021-04 | Journal article
DOI: 10.1136/bcr-2020-240004
Contributors: Daniel Kleinloog; Jacinta Maas; Jorge Lopez Matta; Carlos Elzo Kraemer
Source: check_circle
Crossref

Triage after drug overdose: effect of the Introduction of a medical psychiatry unit on the allocation of ICU beds.

2015 | Journal article
PMC: PMC4472763
Contributors: Kleinloog D; Houckgeest FB; Sierink D
Source: Self-asserted source
D Kleinloog via Europe PubMed Central

Subjective Effects of Ethanol, Morphine, Δ(9)-Tetrahydrocannabinol, and Ketamine Following a Pharmacological Challenge Are Related to Functional Brain Connectivity.

2015-09 | Journal article
PMID: 26390148
Contributors: Kleinloog D; Rombouts S; Zoethout R; Klumpers L; Niesters M; Khalili-Mahani N; Dahan A; van Gerven J
Source: Self-asserted source
D Kleinloog via Europe PubMed Central

Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.

2015-04 | Journal article
DOI: 10.1177/0269881115570082
PMID: 25693889
Contributors: Kleinloog D; Uit den Boogaard A; Dahan A; Mooren R; Klaassen E; Stevens J; Freijer J; van Gerven J
Source: Self-asserted source
D Kleinloog via Europe PubMed Central

The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol.

2014-12 | Journal article
PMID: 25454117
Contributors: Kleinloog D; Stevens J; Heuberger J; Spinhoven P; van Gerven J
Source: Self-asserted source
D Kleinloog via Europe PubMed Central

Profiling the subjective effects of Δ⁹-tetrahydrocannabinol using visual analogue scales.

2014-06 | Journal article
DOI: 10.1002/mpr.1424
PMID: 24496889
Contributors: Kleinloog D; Roozen F; De Winter W; Freijer J; Van Gerven J
Source: Self-asserted source
D Kleinloog via Europe PubMed Central

Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.

2013-04 | Journal article
PMID:

23601084
Contributors: Elling CE; Fridberg M; Jensen NO; Kleinloog HD; Klumpers LE; Little PB; de Kam ML; van Gerven JM
Source: Self-asserted source
D Kleinloog via Europe PubMed Central

Does olanzapine inhibit the psychomimetic effects of Δ⁹-tetrahydrocannabinol?

2012-10 | Journal article
DOI:

10.1177/0269881112446534

PMID:

22596206
Contributors: Hijman R; Jacobs G; Klaassen E; Kleinloog D; Liem-Moolenaar M; de Kam M; van Gerven J
Source: Self-asserted source
D Kleinloog via Europe PubMed Central

Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.

2012-07 | Journal article
DOI:

10.1111/j.1365-2125.2012.04164.x

PMID:

22680341
Contributors: Beumer TL; Freijer JI; Karger LB; Kleinloog HD; Klumpers LE; Lipplaa A; de Kam ML; van Gerven JM; van Hasselt JG
Source: Self-asserted source
D Kleinloog via Europe PubMed Central

Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.

2011-12 | Journal article
PMID:

22220975
Contributors: Beumer TL; Freijer JI; Karger LB; Kleinloog HD; Klumpers LE; Lipplaa A; de Kam ML; van Gerven JM; van Hasselt JG
Source: Self-asserted source
D Kleinloog via Europe PubMed Central

Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients.

2007 | Journal article
DOI:

10.1310/hct0805-282

PMID:

17956829
Contributors: Airoldi M; Arici C; Bombana E; Callegaro A; Kleinloog HD; Maggiolo F; Ravasio V; Suter F
Source: Self-asserted source
D Kleinloog via Europe PubMed Central

Peer review (4 reviews for 1 publication/grant)

Review activity for BMJ case reports. (4)
How many people are using ORCID?